- HHS lays groundwork for new FDA rule on releasing CRLsThe Trump administration is pushing the FDA to cement the details behind its proactive public release of rejection letters sent to pharma companies. The push comes as an HHS spokesperson confirmed…Endpoints · 18d ago↗ source
- AstraZeneca, GSK intensify China ties with Sino Biopharm deals<figure><div><img src="https://imgproxy.divecdn.com/3-9P49KCrlRGe6xhfhkhh6gwLyPKxhxZ8qnm4B-ZxSg/g:nowe:0:158/c:2000:1129/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlc…BioPharma Dive · 18d ago↗ source
- Affordable Care Act insurers want more premium increases as enrollment sagsFor the second year in a row, many Affordable Care Act insurers are proposing double-digit premium increases, driven by rising medical costs as well as federal policy changes.